ACM
ACET icon

ADAR1 Capital Management’s Adicet Bio ACET Stock Holding History

ADAR1 Capital Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$367K Sell
53,827
-74,819
-58% -$560K 0.02% 225
2025
Q4 		$1.08M Buy
+128,646
New +$1.42M 0.08% 126
2024
Q2 		– Sell
-1,952
Closed -$73.4K – 267
2024
Q1 		$73.4K Buy
+1,952
New +$80.8K 0.02% 162

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

ADAR1 Capital Management's ACET Position: Q1 2026 in Review

ADAR1 Capital Management reduced its Adicet Bio (ACET) stake by 58% in Q1 2026, selling an estimated $560K and leaving 53,827 shares worth $367K. The position accounts for 0.02% of the portfolio, ranked #225.

ADAR1 Capital Management first reported a position in ACET in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.08M in Q4 2025. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • ADAR1 Capital Management held 53,827 shares of Adicet Bio worth $367K as of Q1 2026.
  • ADAR1 Capital Management sold 74,819 Adicet Bio shares in Q1 2026, an estimated $560K.
  • Adicet Bio made up 0.02% of ADAR1 Capital Management's portfolio in Q1 2026, its #225 holding.
  • ADAR1 Capital Management first reported a position in Adicet Bio in Q1 2024 and has held it in 3 quarters since.
  • ADAR1 Capital Management's Adicet Bio position peaked at $1.08M in Q4 2025.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.